These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9239478)

  • 1. Three-dimensional conformal therapy (3D-CRT) for prostate cancer.
    Chuba PJ; Porter AT; Forman JD
    Cancer Treat Res; 1996; 88():147-65. PubMed ID: 9239478
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid Arc, helical tomotherapy, sliding window intensity modulated radiotherapy and three dimensional conformal radiation for localized prostate cancer: a dosimetric comparison.
    Kinhikar RA; Pawar AB; Mahantshetty U; Murthy V; Dheshpande DD; Shrivastava SK
    J Cancer Res Ther; 2014; 10(3):575-82. PubMed ID: 25313742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity.
    Pollack A; Zagars GK; Starkschall G; Childress CH; Kopplin S; Boyer AL; Rosen II
    Int J Radiat Oncol Biol Phys; 1996 Feb; 34(3):555-64. PubMed ID: 8621278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of benchmark dose-volume histograms for selection of the optimal technique between three-dimensional conformal radiation therapy and intensity-modulated radiation therapy in prostate cancer.
    Luo C; Yang CC; Narayan S; Stern RL; Perks J; Goldberg Z; Ryu J; Purdy JA; Vijayakumar S
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1253-62. PubMed ID: 17145540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
    Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
    Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of IMRT in reducing penile doses in dose escalation for prostate cancer.
    Sethi A; Mohideen N; Leybovich L; Mulhall J
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):970-8. PubMed ID: 12605975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rush to judgment: Does the evidence support the enthusiasm over three-dimensional conformal radiation therapy and dose escalation in the treatment of prostate cancer?
    Levitt SH; Khan FM
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):871-9. PubMed ID: 11704309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anal wall sparing effect of an endorectal balloon in 3D conformal and intensity-modulated prostate radiotherapy.
    Smeenk RJ; van Lin EN; van Kollenburg P; Kunze-Busch M; Kaanders JH
    Radiother Oncol; 2009 Oct; 93(1):131-6. PubMed ID: 19523704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurovascular Bundle Infiltration Can Explain Local Relapses Using Conformal Radiotherapy of Prostate Cancer.
    Johansson AK; Lennernäs B; Isacsson U
    Anticancer Res; 2017 Apr; 37(4):1825-1830. PubMed ID: 28373447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
    Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RTOG 94-06: is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity?
    Valicenti RK; Winter K; Cox JD; Sandler HM; Bosch W; Vijayakumar S; Michalski J; Purdy J
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):614-20. PubMed ID: 14529764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing intensity modulated radiotherapy to the prostate bed: dosimetric study and early clinical results.
    Riou O; Laliberté B; Azria D; Menkarios C; Llacer Moscardo C; Dubois JB; Aillères N; Fenoglietto P
    Med Dosim; 2013; 38(2):117-21. PubMed ID: 23237661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of real-time couch tracking during 3-dimensional conformal radiation therapy, intensity modulated radiation therapy, and volumetric modulated arc therapy for prostate cancer.
    Wilbert J; Baier K; Hermann C; Flentje M; Guckenberger M
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):237-42. PubMed ID: 22541958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three dimensional conformal radiation therapy, intensity modulated radiation therapy and volumetric modulated arc therapy for low radiation exposure of normal tissue in patients with prostate cancer.
    Cakir A; Akgun Z; Fayda M; Agaoglu F
    Asian Pac J Cancer Prev; 2015; 16(8):3365-70. PubMed ID: 25921146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct effects of rectum delineation methods in 3D-conformal vs. IMRT treatment planning of prostate cancer.
    Guckenberger M; Meyer J; Baier K; Vordermark D; Flentje M
    Radiat Oncol; 2006 Sep; 1():34. PubMed ID: 16956403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a phase II study using estramustine phosphate and vinblastine in combination with high-dose three-dimensional conformal radiotherapy for patients with locally advanced prostate cancer.
    Zelefsky MJ; Kelly WK; Scher HI; Lee H; Smart T; Metz E; Schwartz L; Fuks Z; Leibel SA
    J Clin Oncol; 2000 May; 18(9):1936-41. PubMed ID: 10784635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer.
    Pinkawa M; Corral NE; Caffaro M; Piroth MD; Holy R; Djukic V; Otto G; Schoth F; Eble MJ
    Radiother Oncol; 2011 Sep; 100(3):436-41. PubMed ID: 21963289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison and limitations of DVH-based NTCP models derived from 3D-CRT and IMRT data for prediction of gastrointestinal toxicities in prostate cancer patients by using propensity score matched pair analysis.
    Troeller A; Yan D; Marina O; Schulze D; Alber M; Parodi K; Belka C; Söhn M
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):435-43. PubMed ID: 25636766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical analysis of dose-volume and dose-wall histograms for rectal toxicity following 3D-CRT in prostate cancer.
    García-Vicente F; Zapatero A; Floriano A; Cruz-Conde A; Perez L; Marín A; Mínguez C; Torres JJ
    Med Phys; 2005 Aug; 32(8):2503-9. PubMed ID: 16193780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.
    Michalski JM; Purdy JA; Winter K; Roach M; Vijayakumar S; Sandler HM; Markoe AM; Ritter MA; Russell KJ; Sailer S; Harms WB; Perez CA; Wilder RB; Hanks GE; Cox JD
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):391-402. PubMed ID: 10661346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.